Operator
Welcome to the Viking Therapeutics 2021 first-quarter financial results conference call. [Operator instructions] As a reminder, this conference call is being recorded today, April 28th, 2021. I would now like to turn the conference over to Viking s manager of investor relations, Stephanie Diaz. Please go ahead, Stephanie.
Stephanie Diaz
Manager of Investor Relations
Hello, and thank you all for participating in today s call. Joining me today is Brian Lian, Viking s president and CEO; and Greg Zante, Viking s CFO. Before we begin, I d like to caution that comments made during this conference call, today, April 28th, 2021, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking s expectations regarding its development activities, timelines, and milestones.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the FibroGen Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Mr. Michael Tung. Thank you. Please go ahead, sir.
Michael Tung
Vice President of Corporate Strategy and Investor Relations
Thank you, Linda and good afternoon, everyone. I m Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroGen. Joining me on today s are Enrique Conterno, our Chief Executive Officer; Dr. Percy Carter, our Chief Scientific Officer; Pat Cotroneo, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Thane Wettig, our Chief Commercial Officer; Chris Chung, our Senior Vice President of China Operations; and Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety, and Pharmacovigilance. The format for today s call includes prepared remarks fro
Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.